Anti-LFA-1 monoclonal antibody in renal transplantation: renal function, infections, and other complications.
Spillner
J
J
Department of Cardiothoracic Surgery, University Hospital Essen, Germany.
Kohnle
M
M
Albrecht
K H
KH
Heemann
U
U
D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D001379:Azathioprine / Q000627:therapeutic use; D003141:Communicable Diseases / Q000453:epidemiology; D003404:Creatinine / Q000097:blood; D016572:Cyclosporine / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D006801:Humans; D007165:Immunosuppression Therapy / Q000379:methods*; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D016030:Kidney Transplantation / Q000276:immunology* / Q000502:physiology; D016169:Lymphocyte Function-Associated Antigen-1 / Q000276:immunology*; D011183:Postoperative Complications / Q000453:epidemiology; D011241:Prednisone / Q000627:therapeutic use; D014552:Urinary Tract Infections / Q000453:epidemiology
D000911:Antibodies, Monoclonal; D007166:Immunosuppressive Agents; D016169:Lymphocyte Function-Associated Antigen-1; C114320:anti-LFA-1 monoclonal antibody; D016572:Cyclosporine; D003404:Creatinine; D001379:Azathioprine; D011241:Prednisone